Adderall Not Working? Common Reasons, and What CYP2D6 Can and Cannot Explain

Stimulant doses are found by adjustment, not set in advance. For immediate-release Adderall, the label starts most people aged 6 and over at 5 mg once or twice a day and raises the daily dose by 5 mg at weekly intervals until it works or side effects get in the way.^[1] Adderall XR is also titrated at weekly intervals.^[2] The CDC notes that prescribers may need to try different medicines and doses to find the balance between benefits and side effects.^[10] A low starting dose that does little is expected early on, not a sign that amphetamine cannot work for you.

Immediate-release Adderall is a short-acting product. The label gives the first dose on waking and any extra doses (one or two) at intervals of 4 to 6 hours, and advises against late evening doses because of insomnia.^[1] If it helps in the morning but fades by early afternoon, that is often how the product is designed rather than a failure.

Adderall XR is taken once, on waking, and reaches its peak level about 7 hours later.^[2] A heavy meal does not reduce how much is absorbed, but it delays the peak by about 2.5 hours, so a dose taken with a big breakfast can feel slower.^[2] Proton pump inhibitors such as omeprazole make amphetamine peak sooner.^[1] A change in breakfast routine or a new acid reflux medicine can change how a dose feels through the day.

Amphetamine is cleared partly by the kidneys, and how much leaves unchanged depends heavily on urine pH.^[4] The labels say acidifying agents such as ascorbic acid (vitamin C) lower amphetamine blood levels, and alkalinizing agents such as sodium bicarbonate raise them.^[4][2] Taking vitamin C supplements or effervescent vitamin drinks around your dose is a plausible, checkable reason for a weaker effect.

The common advice about orange juice is less certain than it sounds. The labels name ascorbic acid, not juice, and the Vyvanse label reports that taking a capsule with orange juice did not change how much drug reached the blood.^[3] Antacids work the other way: the labels say gastrointestinal alkalinizing agents should be avoided with Adderall because they raise levels.^[1]

The Adderall and Adderall XR labels both state that the drug may produce tolerance.^[1][2] A dose that worked well at first can feel weaker months later. That is a reason to talk to your prescriber, not to take extra doses: amphetamine is a controlled substance with a risk of misuse and dependence, and the dose should only change under their supervision.^[1]

ADHD often occurs alongside sleep problems, anxiety, depression and learning disorders, which can make it harder to diagnose and treat.^[11] Stimulants can themselves cause difficulty sleeping and loss of appetite.^[10] A run of short nights, untreated anxiety or a low mood can make a working dose look like it has stopped working. These are worth raising with your prescriber alongside any question about the medicine itself.

Some interactions make amphetamine stronger rather than weaker. The labels warn that CYP2D6 inhibitors can increase amphetamine exposure and the risk of serotonin syndrome.^[1] The FDA lists bupropion, fluoxetine, paroxetine, quinidine and terbinafine as strong CYP2D6 inhibitors.^[6] Starting or stopping one of these can change how Adderall feels, in either direction. MAO inhibitors must not be taken with Adderall or within 14 days of stopping one.^[1] Give your prescriber and pharmacist a full list, including supplements.

Immediate-release and extended-release Adderall behave differently through the day, even at the same total daily dose.^[2] Generic versions must contain the same active ingredient at the same strength and be bioequivalent to the brand.^[9] If a dose feels different after a pharmacy change, write down the manufacturer on the label and tell your pharmacist or prescriber.

Supply has also been a real problem. The FDA first posted a shortage of immediate-release mixed amphetamine salts tablets in October 2022, and its shortage database still listed it as current in October 2026.^[8] A shortage can mean a different strength, formulation or manufacturer than usual. Do not split, combine or substitute products on your own to make up for it.

Genetics is one factor among several for amphetamine, and the evidence is thinner than for drugs like codeine or atomoxetine. The labels say the enzymes involved in amphetamine metabolism "have not been clearly defined". CYP2D6 is one known route, and because CYP2D6 varies between people, they say "population variations in amphetamine metabolism are a possibility".^[1] Much of a dose also leaves through the kidneys, where urine pH has a large effect.^[4]

The FDA statement is about higher exposure and side effects in poor metabolizers, not about the drug failing. A poor metabolizer result therefore supports starting low and adjusting carefully; it does not explain a dose that does nothing. In theory an ultrarapid metabolizer could clear amphetamine faster, but there is no FDA guidance for that group.^[5]

Vyvanse (lisdexamfetamine) is a prodrug. The label says it is converted to d-amphetamine and l-lysine "primarily in blood due to the hydrolytic activity of red blood cells", and that lisdexamfetamine is not metabolized by cytochrome P450 enzymes.^[3] So the activation step does not run through the liver or CYP2D6. The d-amphetamine it releases is then handled like other amphetamine: partly by the liver, CYP2D6 among the routes, and partly through the kidneys, with the same urine pH effects.^[3][1] The Vyvanse label carries the same CYP2D6 inhibitor warning as Adderall.^[3] The FDA table has no separate entry for lisdexamfetamine; its poor metabolizer statement sits under amphetamine.^[5]

Our amphetamine evidence page covers the labels, the FDA table and the limits of the evidence in more detail.

A CYP2D6 result is most useful if you have strong side effects at low doses, if you are starting a stimulant and want to know whether the FDA's lower-starting-dose advice applies to you, or if you take other medicines where CYP2D6 matters more, such as some antidepressants, atomoxetine or codeine. It is less likely to explain an Adderall dose that simply does nothing.

The Gene2Rx Psychiatric Report ($35) and Full Report ($50, 120 medications) both include amphetamine. The Starter Report does not. Adderall, Adderall XR and Vyvanse are reported through the same amphetamine result; there is no separate lisdexamfetamine entry.

Know the limits before you buy. Consumer DNA tests such as 23andMe and AncestryDNA are not clinical-grade, and their raw data is labeled not for medical use. Genetics is one factor among many, and a result is something to discuss with your prescriber, not a reason to change your dose yourself.

Usually it means something about the dose, timing or circumstances needs adjusting, not that amphetamine can never work for you. Common causes are a dose that has not been titrated yet, immediate-release doses wearing off after a few hours, vitamin C or other acidifying agents near the dose, poor sleep, tolerance, or a change in product. Bring a short log of doses and effects to your prescriber.^[1][10]

Possibly, but it is not the most likely explanation. CYP2D6 is one of several routes that clear amphetamine, and the FDA's genetic statement covers poor metabolizers, who may have higher exposure and more side effects. It does not describe a group for whom Adderall stops working.^[5][1]

Somewhat. CYP2D6 forms one amphetamine metabolite, 4-hydroxyamphetamine, and the labels say genetic variation in CYP2D6 could cause differences in amphetamine metabolism. The FDA suggests a lower starting dose or another drug for poor metabolizers. CPIC has no amphetamine guideline.^[1][5][7]

Vyvanse (lisdexamfetamine) is converted to d-amphetamine and l-lysine mainly in the blood, by red blood cells. Lisdexamfetamine itself is not metabolized by cytochrome P450 enzymes. Most of a dose ends up in the urine, much of it as amphetamine and hippuric acid, and very little as intact lisdexamfetamine.^[3]

The activation step is not. It happens in the blood. The d-amphetamine that Vyvanse releases is then cleared partly by the kidneys and partly by liver metabolism, as with other amphetamine products. The Vyvanse label sets lower maximum doses for severe kidney impairment.^[3][1]

CYP2D6 does not activate Vyvanse, but it is one of the routes that break down the d-amphetamine it releases. The FDA table has no separate lisdexamfetamine entry; its statement for CYP2D6 poor metabolizers is listed under amphetamine and suggests a lower starting dose or another drug. That is a conversation for your prescriber, not a reason to stop.^[3][5]

The labels say acidifying agents such as ascorbic acid (vitamin C) lower amphetamine blood levels, so a vitamin C supplement near your dose could weaken it. The evidence for juice is less clear: the Vyvanse label found that orange juice taken with a capsule did not change exposure. Ask your pharmacist about timing if you take vitamin C.^[4][3]